The Gaming for Medical Education Research (G4MER) Program
NCT ID: NCT03666468
Last Updated: 2019-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
264 participants
INTERVENTIONAL
2017-07-03
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serious Game Versus Online Course to Pre-train Medical Students on the Management of an Adult Cardiac Arrest.
NCT02758119
Effect of Realistic Simulation and Digital Educational Platforms for Learning Nursing Student
NCT04940455
The Effects of Video Game Warm-up on EyeSi Surgical Simulator Performance
NCT04334486
Evaluating TESLA-G, a Gamified, Telegram-delivered, Quizzing Platform for Surgical Education in Medical Students
NCT05520671
Gamification and Augmented Reality in Mechanical Ventilation Teaching for Nursing Students
NCT05570799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Study 1A (Formerly titled "Serious Games in Medical Education - a Randomised Control Trial") is already underway and involves Phase 3 medical students at UNSW having 8 weeks access to the game, an Online Package (OP) or NSW State Guidelines on Asthma and Seizure management. Students are then assessed using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations (detailed below).
2. Study 1B is also a randomised control trial similar in design to Study 1A, however it will involve doctors and nurses employed at Sydney Children's Hospital. PlayMed will be compared against the HETI Learning Path Paediatric Clinical Practice Guidelines (Online Package for staff).
3. Studies 2A and 2B are identical to Studies 1A and 1B respectively except participants will have 2 hours access to their educational tool. Participants will then immediately undergo the same assessment using multiple choice questions (MCQ) and two observed structure clinical examination (OSCE) stations The proposed study designs are all blinded randomised control trials. Participants may only be involved in Study 1 or Study 2, not both.
Administration
Studies 1A and 1B Participants allocated to the game and to the OP will be given the appropriate access for 8 weeks (instructions provided in the study envelope). Participants allocated to the guidelines will receive a print-out of the guidelines. Participants will be encouraged to engage with their additional educational tool as often as they wish during their eight weeks. In the 8th last week participants will have their knowledge and clinical performance assessed as outlined below.
Studies 2A and 2B Participants allocated to the game, OP and guidelines will be given 2 hours to utilise their assigned teaching tool. Two hours was selected as an appropriate time-frame in which participants would be able complete all cases of the game or online package, or read through the guidelines. Furthermore, it was chosen as it is more pragmatic and better at assessing short-term retention. Computers will be provided for participants to access the game and OP. The guidelines will be printed for participants to read. Participants will then immediately have their knowledge and clinical performance assess as outlined below.
Assessment
Studies 1A, 1B, 2A and 2B Participants will be assessed for knowledge acquisition and clinical performance. Participant knowledge will be assessed using 10 multiple choice questions (MCQ). Participant clinical skills will be assessed via an observed structured clinical examination (OSCE) administered in the simulation laboratory (immediately after the knowledge test); participants will be tested across two clinical scenarios. Strict marking criteria will be used to ensure standardisation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PlayMed
PlayMed, a highly immersive role-playing computer game
\- Focus on Paediatric Asthma and Seizure management
PlayMed
A highly immersive role-playing computer game focused on Paediatric Asthma and Seizure management
Online Package (OP)
Online package (OP) of NSW Health Guidelines
\- Focus on Paediatric Asthma and Seizure management
Online Package
Online package (OP) of NSW Health Guidelines focused on Paediatric Asthma and Seizure management
Paper Guidelines
Paper NSW Health Guidelines
\- Focus on Paediatric Asthma and Seizure management
Paper Guidelines
Paper NSW Health Guideline focused on Paediatric Asthma and Seizure management
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PlayMed
A highly immersive role-playing computer game focused on Paediatric Asthma and Seizure management
Online Package
Online package (OP) of NSW Health Guidelines focused on Paediatric Asthma and Seizure management
Paper Guidelines
Paper NSW Health Guideline focused on Paediatric Asthma and Seizure management
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Studies 1B and 2B Doctors and nurses employed at Sydney Children's Hospital.
Exclusion Criteria
* Studies 1B and 2B Doctors and nurses not actively employed at Sydney Children's Hospital.
20 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of New South Wales
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Michael Coffey
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael J Coffey, BMed MD
Role: PRINCIPAL_INVESTIGATOR
The University of New South Wales
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sydney Children's Hospital
Randwick, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HC17160-LNR/17/SCHN/194
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.